Human T-lymphotropic virus 1: recent knowledge about an ancient infection
K Verdonck, E González, S Van Dooren… - The Lancet infectious …, 2007 - thelancet.com
Human T-lymphotropic virus 1 (HTLV-1) has infected human beings for thousands of years,
but knowledge about the infection and its pathogenesis is only recently emerging. The virus …
but knowledge about the infection and its pathogenesis is only recently emerging. The virus …
Human T-lymphotropic virus type I infection
A Manns, M Hisada, L La Grenade - The Lancet, 1999 - thelancet.com
Human T-cell lymphotropic virus type I (HTLV-I) is the first human retrovirus to be associated
with malignant disease—namely, adult T-cell leukaemia/lymphoma. HTLV-I has also been …
with malignant disease—namely, adult T-cell leukaemia/lymphoma. HTLV-I has also been …
[PDF][PDF] Human T-lymphotropic virus type 1: technical report
World Health Organization - 2021 - apps.who.int
The human T-lymphotropic virus type 1 (HTLV-1, also known as the human T-cell leukaemia
virus type 1) has been shown to cause severe disease in some people infected with the …
virus type 1) has been shown to cause severe disease in some people infected with the …
HTLV-1 infections
CRM Bangham - Journal of clinical pathology, 2000 - jcp.bmj.com
Human T lymphotropic virus type 1 (HTLV-1) causes disabling and fatal diseases, yet there
is no vaccine, no satisfactory treatment, and no means of assessing the risk of disease or …
is no vaccine, no satisfactory treatment, and no means of assessing the risk of disease or …
Reducing the global burden of HTLV-1 infection: an agenda for research and action
Even though an estimated 10–20 million people worldwide are infected with the oncogenic
retrovirus, human T-lymphotropic virus type 1 (HTLV-1), its epidemiology is poorly …
retrovirus, human T-lymphotropic virus type 1 (HTLV-1), its epidemiology is poorly …
[HTML][HTML] HTLV-1 infection: An emerging risk. Pathogenesis, epidemiology, diagnosis and associated diseases
E Eusebio-Ponce, E Anguita… - Revista Española de …, 2019 - ncbi.nlm.nih.gov
ABSTRACT The Human T-Lymphotropic Virus type 1 (HTLV-1) affects up to 10 million
people worldwide. It is directly associated to one of the most aggressive T cell malignancies …
people worldwide. It is directly associated to one of the most aggressive T cell malignancies …
[HTML][HTML] Current status of HTLV-1 infection
T Watanabe - International journal of hematology, 2011 - Springer
It is 30 years since human T-cell leukemia virus type 1 (HTLV-1) was identified as the first
human retrovirus. To assess the implications of the virus for human health it is very important …
human retrovirus. To assess the implications of the virus for human health it is very important …
Incidence of human T-lymphotropic virus 1 infection in adolescent and adult blood donors in Japan: a nationwide retrospective cohort analysis
M Satake, M Iwanaga, Y Sagara… - The Lancet Infectious …, 2016 - thelancet.com
Background Human T-lymphotropic virus 1 (HTLV-1) infection has an especially high
prevalence in Japan. Transmission has been confirmed in infancy through breastfeeding; …
prevalence in Japan. Transmission has been confirmed in infancy through breastfeeding; …
[HTML][HTML] Rapid dissemination of human T-lymphotropic virus type 1 during primary infection in transplant recipients
Background Human T-lymphotropic virus type 1 (HTLV-1) infects an estimated 10 million
persons globally with transmission resulting in lifelong infection. Disease, linked to high …
persons globally with transmission resulting in lifelong infection. Disease, linked to high …
Global epidemic of human T-cell lymphotropic virus type-I (HTLV-I)
RF Edlich, JA Arnette, FM Williams - The Journal of emergency medicine, 2000 - Elsevier
Infection with human T-cell lymphotrophic virus-I (HTLV-I) is now a global epidemic, affecting
10 million to 20 million people. This virus has been linked to life-threatening, incurable …
10 million to 20 million people. This virus has been linked to life-threatening, incurable …